Year: 2021

SAMPO PLC                 STOCK EXCHANGE RELEASE         14/12/2021 at 08:30 am Sampo plc’s share buybacks 13/12/2021 On 13/12/2021 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  32,296 43.99 AQEU  37,944 43.98 CEUX  5,127 44.00 TQEX  97,079 44.01 XHELTOTAL 172,446 44.00  *rounded to two decimals                 On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021,...

Utrecht, 14 December 2021   Aalberts N.V. has reached an agreement to divest 100% of the shares of Standard Hidráulica Group (STH), based in Barcelona (Spain) with locations in United Kingdom, Greece and South Africa, generating an annual revenue of approximately EUR 90 million with 220 employees. The disposal of STH is part of the divestment programme presented in December 2019. We would like to thank the management and all employees of STH for their loyalty and ongoing efforts during the many years of Aalberts ownership. To realise our strategic objectives, Aalberts focuses on four technology clusters with strong market positions, high margin and growth potential and sustainable impact. We continue to optimise our portfolio and allocate our capital in the most efficient way. The results of STH will be deconsolidated as of 1 December...

ERYTECH Announces $7.85 Million Registered Direct OfferingLyon (France) and Cambridge, MA (U.S.), December 14, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP) (the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it has entered into a definitive agreement with Armistice, a health–care focused institutional and accredited investor, for the purchase and sale of 769,608 units (“Units”), each Unit consisting of four ordinary shares in the form of American Depositary Shares (each an “ADS”) and three warrants, each to purchase one ordinary share (each a “Warrant”), in a registered direct offering to specified categories of investors, described below. The subscription price for one Unit is $10.20 (€9.04),...

Pixium Vision to attend 11thAnnual LifeSci Partners Corporate Access EventCEO Lloyd Diamond to participate in a panel discussion on “Med Tech / Digital Tools: What’s the Mindset for 2022?” – January 5, 2022, at 02:00 pm ET / 08:00 pm CETParis, France, December 14, 2021 – 07.00 CET – Pixium Vision SA (Euronext Growth Paris – FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces today that it will attend the 11th Annual LifeSci Partners Corporate Access Event, being held virtually from January 5 to 7, 2022. Lloyd Diamond, CEO of Pixium Vision, will also participate in a panel discussion on “Med Tech / Digital Tools: What’s the Mindset for 2022?” on Wednesday, January 5, 2022, at 02:00 pm ET / 08:00 pm CET. Please register...

Vancouver, British Columbia, Dec. 14, 2021 (GLOBE NEWSWIRE) — Universal Copper Ltd. (“Universal Copper“ or the “Company”) (TSX Venture: UNV) (Frankfurt: 3TA2) is pleased to announce all samples from its recently completed drill program at the Poplar Copper Project (“Poplar”), located southwest of Houston, B.C. have now been shipped to the ALS Minerals Laboratory (“ALS”) in North Vancouver, BC for analysis. As the year draws to a close and with the core at the lab, the Company anticipates that it will be releasing the assay results from our 3,000-metre six-hole program through January and February 2022. Once the results have been released, the Company will initiate metallurgical testing with material from the six holes later in the first quarter. As previously mentioned, the permit extension for...

Collaboration to leverage world class capabilities of Molecular Partners DARPin platform with Novartis’ in radioligand therapy to explore the potential for novel targeted therapies for cancer Novartis will pay $20 million upfront, commercial royalties up to low double-digits, and milestone payments.ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced a collaboration with Novartis in the form of a license agreement to develop, manufacture and commercialize DARPin-conjugated radioligand therapies (DARPin-RLTs). The collaboration will combine Molecular Partners’ industry-leading...

Company announcement no. 30/2021Schindellegi, Switzerland – 14 December 2021Pursuant to the Market Abuse Regulation article 19, Trifork Holding AG (Swiss company registration number CHE-474.101.854) (“Trifork”), hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Trifork and persons closely associated with them in Trifork’s shares and other financial instruments linked thereto.1. Details of the person discharging managerial responsibilities/person closely associateda) Name Blackbird II ApSCVR no. 323272142. Reason for the notificationa) Position/status Blackbird II ApS is a company fully owned by Jørn Larsen, the CEO of Trifork Holding AG.b) Initial notification/ Amendment Initial notification3. Details of the issuer, emission allowance...

SIKA EXPANDS PRODUCTION FOR ADHESIVES AND SEALANTS IN INDIA AND OPENS TECHNOLOGY CENTER Sika is opening a new technology center and manufacturing plant for high-quality adhesives and sealants in Pune, a city in the federal state of Maharashtra. Developments at the new R&D laboratories and the production in the new plant are aimed at meeting the rapidly growing demand in the Indian market. On its three new production lines, Sika mainly manufactures products for the transportation, construction, and renewable energy sectors. Situated 100 kilometers southeast of the port of Mumbai, Pune is one of India’s main industrial centers. The city and its agglomeration represent more than eight million people. Vehicle manufacturers and automotive suppliers in particular have settled in Pune and nearby in the state of Maharashtra. The new Sika...